Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon
Thumbnail

HIMSS launches Value Score for universal quality measurement

HIMSS has launched the HIMSS Value Score, an international quality measurement for the value of health IT.  

Thumbnail

UnitedHealth Group CEO defends possibility of exiting health insurance exchanges

UnitedHealth Group CEO Stephen Hemsley said the health insurer might not offer plans on exchanges created as part of the Patient Protection and Affordable Care Act, Reuters reports. UnitedHealth announced in November that it had suffered significant losses on the exchanges.

Thumbnail

Healthcare CEOs share 2015 moments that stood out

Becker’s Hospital Review received feedback from 20 CEOs in the healthcare industry about which event in 2015 fascinated them the most. 

Why did 11% of organizations call ICD-10 transition a 'failure'?

Another survey indicates that the Oct. 1 transition to ICD-10 went smoothly for most healthcare providers, but 11 percent said it was a failure, according to KPMG. 

Thumbnail

For-profit players have a place in universal healthcare systems: Canadian study

In a study of healthcare systems in six developed nations that could have implications for the U.S.—regardless of the ultimate fate of troubled Obamacare—an influential Canadian think tank has concluded that for-profit hospitals and insurers can survive and thrive under universal health care.

CMS clarifies actions regarding ICD-10 claims problems

Overall, there have been few complaints in the wake of the transition to ICD-10 but a few isolated incidents have led the Centers for Medicare & Medicaid Services (CMS) to issue clarifications on how it's resolving the issues.

New Yorker: Pfizer-Allergan merger a 'disgrace'

Pharmaceutical company Pfizer made headlines on Nov. 23 when it announced its plan to buy Ireland-based Allergan for approximately $160 billion. John Cassidy of The New Yorker wrote about the big news, pointing out that it is widely acknowledged that the deal is happening primarily to help Pfizer avoid paying the U.S. corporate tax rate. 

Pfizer announces historic plan to purchase Allergan

Pharmaceutical company Pfizer announced Monday it is buying Ireland-based Allergan for approximately $160 billion in what would be the largest deal in the history of the healthcare sector. 

Displaying 6369 - 6376 of 8453

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.